Utilizing NGS for Proteomics - Olink® to Accelerate Drug Discovery and Optimize Clinical Trials Outcome



December 5, 2022

  • Share
  • Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Karsten Strauss discussed Olink's acceleration of drug discovery by utilizing NGS for proteomics.

    BiopharmaDrug DiscoveryProteomics and Metabolomics

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.